Similar recommendations have been made for gastroesophageal adenocarcinoma, with the exception that due to characteristic histology, the percentage of tumor cells that exhibit basolateral or lateral, rather than complete, membranous staining is calculated to define HER2 positivity by IHC [47]. This evidence concerns the gene ERBB2 and neoplasm.